These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6373714)

  • 1. The in-vitro activity of metronidazole against strains of Escherichia coli with impaired DNA repair systems.
    Jackson D; Salem A; Coombs GH
    J Antimicrob Chemother; 1984 Mar; 13(3):227-36. PubMed ID: 6373714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of metronidazole and a Bacteroides fragilis metA resistance gene in Escherichia coli.
    Dachs GU; Abratt VR; Woods DR
    J Antimicrob Chemother; 1995 Apr; 35(4):483-96. PubMed ID: 7628983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole.
    Soriano F; Ponte MC; Gaspar MC
    J Clin Pathol; 1982 Oct; 35(10):1150-2. PubMed ID: 6752209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of metronidazole with Escherichia coli deoxyribonucleic acid.
    Malliaros DP; Goldman P
    Biochem Pharmacol; 1991 Oct; 42(9):1739-44. PubMed ID: 1930299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phagocytic activity of polymorphonuclear leukocytes on Escherichia coli previously exposed to metronidazole.
    Morán FJ; González-Roiz C; Pérez-Giraldo C; Hurtado C; Blanco MT; Gómez-Garcia AC; Prieto J
    J Chemother; 1989 Oct; 1(5):298-304. PubMed ID: 2685186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed mechanism for metronidazole resistance in Helicobacter pylori.
    Cederbrant G; Kahlmeter G; Ljungh A
    J Antimicrob Chemother; 1992 Feb; 29(2):115-20. PubMed ID: 1506325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of cefotaxime and metronidazole against bacteroides and Escherichia coli alone and in mixed culture.
    Soriano F; Ponte C; Santamaría M
    J Antimicrob Chemother; 1983 Jul; 12(1):89-92. PubMed ID: 6311784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of metronidazole with DNA repair mutants of Escherichia coli.
    Yeung TC; Beaulieu BB; McLafferty MA; Goldman P
    Antimicrob Agents Chemother; 1984 Jan; 25(1):65-70. PubMed ID: 6367636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfonamide-Derived Four-Component Molecular Hybrids as Novel DNA-Targeting Membrane Active Potentiators against Clinical Escherichia coli.
    Hu YY; Yadav Bheemanaboina RR; Battini N; Zhou CH
    Mol Pharm; 2019 Mar; 16(3):1036-1052. PubMed ID: 30638386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of an amino reduction product of metronidazole in bacterial cultures: lack of bactericidal activity.
    Ehlhardt WJ; Beaulieu BB; Goldman P
    Biochem Pharmacol; 1987 Jan; 36(2):259-64. PubMed ID: 3545214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species.
    Marchese A; Salerno A; Pesce A; Debbia EA; Schito GC
    Chemotherapy; 2000; 46(4):253-66. PubMed ID: 10859431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible repair of oxidative DNA damage in Escherichia coli.
    Demple B; Halbrook J
    Nature; 1983 Aug 4-10; 304(5925):466-8. PubMed ID: 6348554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications].
    González-Soltero R; García-Cañas A; Mohedano RB; Mendoza-Chamizo B; Botello E
    Rev Esp Quimioter; 2015 Jun; 28(3):139-44. PubMed ID: 26032998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a genetic locus associated with metronidazole resistance in Helicobacter pylori.
    Chang KC; Ho SW; Yang JC; Wang JT
    Biochem Biophys Res Commun; 1997 Jul; 236(3):785-8. PubMed ID: 9245734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of nitro-heterocyclic compounds on Escherichia coli.
    Hof H; Chakraborty T; Royer R; Buisson JP
    Drugs Exp Clin Res; 1987; 13(10):635-9. PubMed ID: 3322751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the DNA-repair host-mediated assay for determining the organ distribution of genotoxic factors in mice treated orally with nitro-aromatic compounds.
    Knasmüller S; Kerklaan P; Mohn GR
    Mutat Res; 1986 Feb; 164(1):9-17. PubMed ID: 2419751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic persistence: the role of spontaneous DNA repair response.
    Debbia EA; Roveta S; Schito AM; Gualco L; Marchese A
    Microb Drug Resist; 2001; 7(4):335-42. PubMed ID: 11822773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Examination of the antibacterial action of metronidazole against vibrios and Campylobacter (author's transl)].
    Füzi M
    Zentralbl Bakteriol A; 1981; 249(2):242-6. PubMed ID: 7269853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mismatch repair of cis-diamminedichloroplatinum(II)-induced DNA damage.
    Fram RJ; Cusick PS; Wilson JM; Marinus MG
    Mol Pharmacol; 1985 Jul; 28(1):51-5. PubMed ID: 3894930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.